Related references
Note: Only part of the references are listed.Cerebellar and parkinsonian phenotypes in multiple system atrophy: similarities, differences and survival
Dusan Roncevic et al.
JOURNAL OF NEURAL TRANSMISSION (2014)
Efficacy and safety of rifampicin for multiple system atrophy: a randomised, double-blind, placebo-controlled trial
Phillip A. Low et al.
LANCET NEUROLOGY (2014)
Extracellular α-synuclein-a novel and crucial factor in Lewy body diseases
He-Jin Lee et al.
NATURE REVIEWS NEUROLOGY (2014)
Modulation of α-synuclein fibrillization by ring-fused 2-pyridones: Templation and inhibition involve oligomers with different structure
Istvan Horvath et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2013)
Oxidation and nitration of α-synuclein and their implications in neurodegenerative diseases
Cecilia Chavarria et al.
ARCHIVES OF BIOCHEMISTRY AND BIOPHYSICS (2013)
Prion-like spreading of pathological α-synuclein in brain
Masami Masuda-Suzukake et al.
BRAIN (2013)
A Blood-Brain Barrier (BBB) Disrupter Is Also a Potent α-Synuclein (α-syn) Aggregation Inhibitor A NOVEL DUAL MECHANISM OF MANNITOL FOR THE TREATMENT OF PARKINSON DISEASE (PD)
Ronit Shaltiel-Karyo et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2013)
A randomized clinical trial of lithium in multiple system atrophy
Francesco Sacca et al.
JOURNAL OF NEUROLOGY (2013)
The natural history of multiple system atrophy: a prospective European cohort study
Gregor K. Wenning et al.
LANCET NEUROLOGY (2013)
Properties of native brain α-synuclein
Jacqueline Burre et al.
NATURE (2013)
Microglia Multiple roles in surveillance, circuit shaping, and response to injury
Eduardo E. Benarroch
NEUROLOGY (2013)
Transmission of multiple system atrophy prions to transgenic mice
Joel C. Watts et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2013)
Systemic proteasome inhibition triggers neurodegeneration in a transgenic mouse model expressing human α-synuclein under oligodendrocyte promoter: implications for multiple system atrophy
Nadia Stefanova et al.
ACTA NEUROPATHOLOGICA (2012)
A Randomized Trial of Mesenchymal Stem Cells in Multiple System Atrophy
Phil Hyu Lee et al.
ANNALS OF NEUROLOGY (2012)
Are Trials of Intravascular Infusions of Autologous Mesenchymal Stem Cells in Patients with Multiple System Atrophy Currently Justified, and Are They Effective?
Phillip A. Low et al.
ANNALS OF NEUROLOGY (2012)
Binding of neuronal α-synuclein to β-III tubulin and accumulation in a model of multiple system atrophy
Kimiko Nakayama et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2012)
Differential inhibition of α-synuclein oligomeric and fibrillar assembly in parkinson's disease model by cinnamon extract
Ronit Shaltiel-Karyo et al.
BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS (2012)
Treatment of multiple system atrophy using intravenous immunoglobulin
Peter Novak et al.
BMC NEUROLOGY (2012)
Fluoxetine rescues impaired hippocampal neurogenesis in a transgenic A53T synuclein mouse model
Zacharias Kohl et al.
EUROPEAN JOURNAL OF NEUROSCIENCE (2012)
Fluoxetine ameliorates behavioral and neuropathological deficits in a transgenic model mouse of α-synucleinopathy
Kiren Ubhi et al.
EXPERIMENTAL NEUROLOGY (2012)
Role of α-synuclein penetration into the membrane in the mechanisms of oligomer pore formation
Igor F. Tsigelny et al.
FEBS JOURNAL (2012)
G-Protein-Coupled Receptor 30 Mediates Rapid Neuroprotective Effects of Estrogen via Depression of NR2B-Containing NMDA Receptors
Shui-bing Liu et al.
JOURNAL OF NEUROSCIENCE (2012)
Antibody-Aided Clearance of Extracellular α-Synuclein Prevents Cell-to-Cell Aggregate Transmission
Eun-Jin Bae et al.
JOURNAL OF NEUROSCIENCE (2012)
Suppression of dynamin GTPase decreases α-synuclein uptake by neuronal and oligodendroglial cells: a potent therapeutic target for synucleinopathy
Masatoshi Konno et al.
MOLECULAR NEURODEGENERATION (2012)
Maintaining glottic opening in multiple system atrophy: Efficacy of serotonergic therapy
Tetsutaro Ozawa et al.
MOVEMENT DISORDERS (2012)
Oligodendroglia metabolically support axons and contribute to neurodegeneration
Youngjin Lee et al.
NATURE (2012)
Evidence-based guideline: Intravenous immunoglobulin in the treatment of neuromuscular disorders Report of the Therapeutics and Technology Assessment Subcommittee of the American Academy of Neurology
H. S. Patwa et al.
NEUROLOGY (2012)
Myeloperoxidase Inhibition Ameliorates Multiple System Atrophy-Like Degeneration in a Transgenic Mouse Model
Nadia Stefanova et al.
NEUROTOXICITY RESEARCH (2012)
Neuroprotective Effect of Human Mesenchymal Stem Cells in an Animal Model of Double Toxin-Induced Multiple System Atrophy Parkinsonism
Hyun-Jung Park et al.
CELL TRANSPLANTATION (2011)
α-Synuclein propagates from mouse brain to grafted dopaminergic neurons and seeds aggregation in cultured human cells
Christian Hansen et al.
JOURNAL OF CLINICAL INVESTIGATION (2011)
Explaining ADAGIO: A critical review of the biological basis for the clinical effects of rasagiline
Peter Jenner et al.
MOVEMENT DISORDERS (2011)
α-Synuclein occurs physiologically as a helically folded tetramer that resists aggregation
Tim Bartels et al.
NATURE (2011)
Fluoxetine protects neurons against microglial activation-mediated neurotoxicity
Feng Zhang et al.
PARKINSONISM & RELATED DISORDERS (2011)
Mesenchymal Stem Cells in a Transgenic Mouse Model of Multiple System Atrophy: Immunomodulation and Neuroprotection
Sylvia Stemberger et al.
PLOS ONE (2011)
Passive Immunization Reduces Behavioral and Neuropathological Deficits in an Alpha-Synuclein Transgenic Model of Lewy Body Disease
Eliezer Masliah et al.
PLOS ONE (2011)
Brain alpha-synuclein accumulation in multiple system atrophy, Parkinson's disease and progressive supranuclear palsy: a comparative investigation
Junchao Tong et al.
BRAIN (2010)
Specific antibodies to soluble alpha-synuclein conformations in intravenous immunoglobulin preparations
L. M. Patrias et al.
CLINICAL AND EXPERIMENTAL IMMUNOLOGY (2010)
Riluzole, Neuroprotection and Amyotrophic Lateral Sclerosis
B. C. Cheah et al.
CURRENT MEDICINAL CHEMISTRY (2010)
Entacapone and Tolcapone, Two Catechol O-Methyltransferase Inhibitors, Block Fibril Formation of α-Synuclein and β-Amyloid and Protect against Amyloid-induced Toxicity
Saviana Di Giovanni et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Direct Transfer of α-Synuclein from Neuron to Astroglia Causes Inflammatory Responses in Synucleinopathies
He-Jin Lee et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2010)
Neurodegeneration in a Transgenic Mouse Model of Multiple System Atrophy Is Associated with Altered Expression of Oligodendroglial-Derived Neurotrophic Factors
Kiren Ubhi et al.
JOURNAL OF NEUROSCIENCE (2010)
Minocycline 1-Year Therapy in Multiple-System-Atrophy: Effect on Clinical Symptoms and [11C] (R)-PK11195 PET (MEMSA-Trial)
Richard Dodel et al.
MOVEMENT DISORDERS (2010)
Presentation, Diagnosis, and Management of Multiple System Atrophy in Europe: Final Analysis of the European Multiple System Atrophy Registry
Martin Koellensperger et al.
MOVEMENT DISORDERS (2010)
Role of TPPP/p25 on α-synuclein-mediated oligodendroglial degeneration and the protective effect of SIRT2 inhibition in a cellular model of multiple system atrophy
Takafumi Hasegawa et al.
NEUROCHEMISTRY INTERNATIONAL (2010)
Inhibiting α-Synuclein Oligomerization by Stable Cell-Penetrating β-Synuclein Fragments Recovers Phenotype of Parkinson's Disease Model Flies
Ronit Shaltiel-Karyo et al.
PLOS ONE (2010)
Glutamate receptors, neurotoxicity and neurodegeneration
Anthony Lau et al.
PFLUGERS ARCHIV-EUROPEAN JOURNAL OF PHYSIOLOGY (2010)
Microtubule Depolymerization Suppresses α-Synuclein Accumulation in a Mouse Model of Multiple System Atrophy
Kimiko Nakayama et al.
AMERICAN JOURNAL OF PATHOLOGY (2009)
β-Sheet-breaking peptides inhibit the fibrillation of human α-synuclein
You Soon Kim et al.
BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS (2009)
Mitochondrial Inhibitor 3-Nitroproprionic Acid Enhances Oxidative Modification of Alpha-synuclein in a Transgenic Mouse Model of Multiple System Atrophy
Kiren Ubhi et al.
JOURNAL OF NEUROSCIENCE RESEARCH (2009)
GLUTAMATERGIC SIGNALING IN THE BRAIN'S WHITE MATTER
Y. Bakiri et al.
NEUROSCIENCE (2009)
A Double-Blind, Delayed-Start Trial of Rasagiline in Parkinson's Disease
C. Warren Olanow et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
Inclusion formation and neuronal cell death through neuron-to-neuron transmission of α-synuclein
Paula Desplats et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2009)
Are trials of intravascular infusions of autologous mesenchymal stem cells in patients with multiple system atrophy currently justified, and are they effective?
N. Quinn et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Rasagiline is neuroprotective in a transgenic model of multiple system atrophy
Nadia Stefanova et al.
EXPERIMENTAL NEUROLOGY (2008)
The Expression of Tubulin Polymerization Promoting Protein TPPP/p25α is Developmentally Regulated in Cultured Rat Brain Oligodendrocytes and Affected by Proteolytic Stress
Olaf Goldbaum et al.
GLIA (2008)
Assembly-dependent endocytosis and clearance of extracellular alpha-synuclein
He-Jin Lee et al.
INTERNATIONAL JOURNAL OF BIOCHEMISTRY & CELL BIOLOGY (2008)
The efficacy of combined estrogen and buspirone treatment in olivopontocerebellar atrophy
Jae-Hyeok Heo et al.
JOURNAL OF THE NEUROLOGICAL SCIENCES (2008)
P2X7 Receptors in Oligodendrocytes: A Novel Target for Neuroprotection
Carlos Matute
MOLECULAR NEUROBIOLOGY (2008)
Associations between multiple system atrophy and polymorphisms of SLC1A4, SQSTM1, and EIF4EBP1 genes
Hiroyuki Soma et al.
MOVEMENT DISORDERS (2008)
Non-steroidal anti-inflammatory drugs have potent anti-fibrillogenic and fibril-destabilizing effects for α-synuclein fibrils in vitro
Mie Hirohata et al.
NEUROPHARMACOLOGY (2008)
Rifampicin reduces α-synuclein in a transgenic mouse model of multiple system atrophy
Kiren Ubhi et al.
NEUROREPORT (2008)
Autologous mesenchymal stem cell therapy delays the progression of neurological deficits in patients with multiple system atrophy
P. H. Lee et al.
CLINICAL PHARMACOLOGY & THERAPEUTICS (2008)
Origins and effects of extracellular alpha-synuclein: Implications in Parkinson's disease
Seung-Jae Lee
JOURNAL OF MOLECULAR NEUROSCIENCE (2008)
Microglial activation mediates neurodegeneration related to oligodendroglial α-synucleinopathy:: Implications for multiple system atrophy
Nadia Stefanova et al.
MOVEMENT DISORDERS (2007)
White matter NMDA receptors: an unexpected new therapeutic target?
Peter K. Stys et al.
TRENDS IN PHARMACOLOGICAL SCIENCES (2007)
Multiple system atrophy:: α-synuclein and neuronal degeneration
Mari Yoshida
NEUROPATHOLOGY (2007)
P25α relocalizes in oligodendroglia from myelin to cytoplasmic inclusions in multiple system atrophy
Yun Ju C. Song et al.
AMERICAN JOURNAL OF PATHOLOGY (2007)
Safety and tolerability of growth hormone therapy in multiple system atrophy: A double-blind, placebo-controlled study
Bjorn Holmberg et al.
MOVEMENT DISORDERS (2007)
Minocycline down-regulates MHC II expression in microglia and macrophages through inhibition of IRF-1 and protein kinase C (PKC)α/βII
Maria Nikodemova et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2007)
System xc- and glutamate transporter inhibition mediates microglial toxicity to oligodendrocytes
Maria Domercq et al.
JOURNAL OF IMMUNOLOGY (2007)
Microglial activation and its implications in the brain diseases
S. Thameem Dheen et al.
CURRENT MEDICINAL CHEMISTRY (2007)
Neurotransmitter-mediated calcium signalling in oligodendrocyte physiology and pathology
Arthur M. Butt
GLIA (2006)
Cytosolic catechols inhibit α-synuclein aggregation and facilitate the formation of intracellular soluble oligomeric intermediates
Joseph R. Mazzulli et al.
JOURNAL OF NEUROSCIENCE (2006)
Cellular pathology in multiple system atrophy
Koichi Wakabayashi et al.
NEUROPATHOLOGY (2006)
Mesenchymal stem cells as trophic mediators
Arnold I. Caplan et al.
JOURNAL OF CELLULAR BIOCHEMISTRY (2006)
Activation of kainate receptors sensitizes oligodendrocytes to complement attack
E Alberdi et al.
JOURNAL OF NEUROSCIENCE (2006)
Paroxetine treatment improves motor symptoms in patients with multiple system atrophy
Elisabeth Friess et al.
PARKINSONISM & RELATED DISORDERS (2006)
Absence of α-synuclein mRNA expression in normal and multiple system atrophy oligodendroglia
DW Miller et al.
JOURNAL OF NEURAL TRANSMISSION (2005)
Riluzole improves motor deficits and attenuates loss of striatal neurons in a sequential double lesion rat model of striatonigral degeneration (parkinson variant of multiple system atrophy)
C Scherfler et al.
JOURNAL OF NEURAL TRANSMISSION (2005)
Peroxynitrite generated by inducible nitric oxide synthase and NADPH oxidase mediates microglial toxicity to oligodendrocytes
JR Li et al.
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA (2005)
Oxidative stress in transgenic mice with oligodendroglial α-synuclein overexpression replicates the neuropathology of multiple system atrophy
N Stefanova et al.
AMERICAN JOURNAL OF PATHOLOGY (2005)
P25α stimulates a-synuclein aggregation and is co-localized with aggregated α-synuclein in α-synucleinopathies
E Lindersson et al.
JOURNAL OF BIOLOGICAL CHEMISTRY (2005)
Microglial activation parallels system degeneration in multiple system atrophy
K Ishizawa et al.
JOURNAL OF NEUROPATHOLOGY AND EXPERIMENTAL NEUROLOGY (2004)
Specific induction of neuronal cells from bone marrow stromal cells and application for autologous transplantation
M Dezawa et al.
JOURNAL OF CLINICAL INVESTIGATION (2004)
[11C](R)-PK11195 PET imaging of microglial activation in multiple system atrophy
A Gerhard et al.
NEUROLOGY (2003)
Progression and prognosis in multiple system atrophy - An analysis of 230 Japanese patients
H Watanabe et al.
BRAIN (2002)
Direct binding and functional coupling of α-synuclein to the dopamine transporters accelerate dopamine-induced apoptosis
FJS Lee et al.
FASEB JOURNAL (2001)
Oxidative damage linked to neurodegeneration by selective α-synuclein nitration in synucleinopathy lesions
BI Giasson et al.
SCIENCE (2000)
Glial cell line-derived neurotrophic factor-like immunoreactivity in the cerebella of normal subjects and patients with multiple system atrophy
Y Kawamoto et al.
ACTA NEUROPATHOLOGICA (2000)
Share Paper
